This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1999.
Company Filing History:
1 out of 834,411 Years Active: 1999
Title: Kirsi Sainio: Innovator in Kidney Morphogenesis
Introduction
Kirsi Sainio is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of kidney morphogenesis through her innovative research and patents. Her work focuses on the regulation of glial cell line-derived neurotrophic factor (GDNF) and its effects on ureteric development.
Latest Patents
Kirsi Sainio holds a patent titled "Glial cell line-derived neurotrophic factor regulation of ureteric." This patent discloses the effects of GDNF on kidney morphogenesis. It includes methods for stimulating budding and branching of the ureteric epithelium, promoting axonal outgrowth, maintaining ureteric epithelial cells in culture, preventing apoptosis of these cells, and treating diseases using GDNF. She has 1 patent to her name.
Career Highlights
Throughout her career, Kirsi has focused on the intricate processes involved in kidney development. Her research has provided valuable insights into the mechanisms that govern ureteric branching and epithelial cell survival. This work has implications for understanding kidney diseases and potential therapeutic approaches.
Collaborations
Kirsi has collaborated with notable colleagues, including Petro Suvanto and Maria Lindahl. These partnerships have enhanced her research and contributed to the advancement of knowledge in her field.
Conclusion
Kirsi Sainio is a dedicated inventor whose work in kidney morphogenesis has the potential to impact medical science significantly. Her innovative approaches and research findings continue to pave the way for future advancements in the treatment of kidney-related diseases.